FORM C

Securities and Exchange Board of India (Prohibition of Insider Tr

[Regulations 7(2) read with Regulation 6(2

Name of the Company: Dr. Reddy’s Laboratories Limited

ISIN of the Company:

Details of change in holding of Securities of Promoter, Employee or D
and other such persons as mentioned in Regulat
Name, PAN No. & address of Category of Securities held prior to acquisition / sale Securities acquired / sold
Promoter / Emplyee / Director Person

Type of security No. and % of Type of security No. and % of Value

(For eg - Shares, shareholding (For eg - Shares, shareholding
Warrants, Warrants,
Convertible Convertible
debentures etc.) debentures etc.

1 2 3 4 5 6 7
Name:
PAN:
Address:
Contact:

Note: “Securities” shall have the meaning as defined under regulation 2(1)(i) of SEBI (Prohibition of Insider Trading) Regulations, 2015.

Trading in derivatives (Specify type of contract, Futures or Options etc)

Type of Contract Contract Buy Sell
Specifications
Exchange on which th
 Type of Contract Contract
Specifications
Number of Exchange on which th
Number of units
units
Value (Contracts* Lot Value
(Contracts*
size)
Lot size)
15 16 17 18 19 20 21

Note: In case of options, notional value shall be calculated based on Premium plus strike price of options
Date: Signature:
Place: Designation:
 of Insider Trading) Regulations, 2015
Regulation 6(2)]

mployee or Director of a Listed Company

ed in Regulation 6(2)
Shares held post acquisition / sale Date of purchase / sale of shares Date of Mode of
intimation to purchase / sale
Company
Transaction Type of security No. and % of From To
Type (For eg - Shares, shareholding
(Buy/Sale/P Warrants,
ledge/Revo Convertible
ke/Invoke debentures etc.

8 9 10 11 12 13 14

ge on which the trade was executed

ge on which the trade was executed

21